Lipid lowering drug has gout prevention benefit, FIELD trial reveals

The lipid-lowering drug fenofibrate could be a useful adjunctive treatment for preventing gout in patients with type 2 diabetes, an Australian trial has shown. Use of fenobibrate reduced uric acid levels by 20% and almost halved incident gout events, a retrospective analysis of a trial involving almost 10,000 patients with type 2 diabetes  has found. ...

Already a member?

Login to keep reading.

© 2021 the limbic